The Effect of Neoadjuvant Chemotherapy on Physical Functions
Launched by ATİYE KAŞ ÖZDEMİR · May 15, 2025
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how neoadjuvant chemotherapy, which is treatment given before surgery for breast cancer, affects physical functioning in women. The researchers want to find out how well participants can move and perform daily activities both before starting chemotherapy and after completing their treatment. To do this, they will measure things like body weight, strength, and balance using simple tests.
Women who are planning to receive neoadjuvant chemotherapy for breast cancer may be eligible to join the study, as long as they haven't had breast cancer before and are willing to participate. Participants can expect to undergo various physical tests at the start and end of their chemotherapy treatment to help researchers understand the impact of the chemotherapy on their physical health. This information could be important for improving care and support for future patients.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Individuals who are planned to receive neoadjuvant chemotherapy for breast cancer
- • Acceptance to participate in the study
- Exclusion Criteria:
- • Previous history of breast cancer
- • History of any other cancer
- • Refusal to participate in the study
- • Refusal to continue working
About Ati̇ye Kaş özdemi̇r
Atiye Kaş Özdemir is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on ethical practices and rigorous scientific methodologies, the organization collaborates with leading healthcare professionals and institutions to facilitate the development of new therapies and treatments. Atiye Kaş Özdemir’s mission is to enhance the understanding of various medical conditions while ensuring participant safety and data integrity throughout the research process. Their commitment to excellence and adherence to regulatory standards positions them as a trusted partner in the clinical research community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Denizli, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported